๐ŸŽ—๏ธ OncologyInjection (IV)

    Yescarta

    Axicabtagene Ciloleucel

    CD19-directed CAR T-cell therapy for relapsed/refractory large B-cell lymphoma and follicular lymphoma.

    Form

    Injection (IV)

    Uses

    3

    Side effects

    5

    Category

    Oncology

    01

    What is Yescarta used for?

    • Relapsed/refractory large B-cell lymphoma
    • Follicular lymphoma
    • Primary mediastinal B-cell lymphoma
    02

    Axicabtagene Ciloleucel side effects

    Common side effects of Axicabtagene Ciloleucel include:

    Cytokine release syndrome
    Neurotoxicity (ICANS)
    Infections
    Cytopenias
    Hypogammaglobulinemia
    CommonModerateLess common
    03

    Axicabtagene Ciloleucel warnings & precautions

    • Black box: CRS and neurological toxicities
    • REMS required
    • Secondary T-cell malignancies reported

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Yescarta in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.